Reassessing potential economic value and health impact of effective Shigella vaccines.

Autor: Hausdorff WP; Center for Vaccine Innovation and Access, PATH, 455 Massachusetts Avenue NW, Washington, D.C.20001, United States of America (USA)., Anderson JD 4th; West Virginia University, Morgantown, West Virginia, USA., Bourgeois AL; Center for Vaccine Innovation and Access, PATH, 455 Massachusetts Avenue NW, Washington, D.C.20001, United States of America (USA)., Clifford A; Center for Vaccine Innovation and Access, PATH, 455 Massachusetts Avenue NW, Washington, D.C.20001, United States of America (USA)., Fleming JA; PATH, Seattle, Washington, USA., Muhib F; Center for Vaccine Innovation and Access, PATH, 455 Massachusetts Avenue NW, Washington, D.C.20001, United States of America (USA)., Pecenka C; PATH, Seattle, Washington, USA., Puett C; Stony Brook University, Stony Brook, New York, USA., Riddle MS; University of Nevada, Reno, Nevada, USA., Scheele S; Center for Vaccine Innovation and Access, PATH, 455 Massachusetts Avenue NW, Washington, D.C.20001, United States of America (USA)., Bagamian KH; Bagamian Scientific Consulting LLC, Gainesville, Florida, USA.

Publikováno v: Bulletin of the World Health Organization [Bull World Health Organ] 2024 Jan 01; Vol. 102 (1), pp. 65-74. Date of Electronic Publication: 2023 Dec 11.

Projecting the long-term economic benefits of reducing Shigella-attributable linear growth faltering with a potential vaccine: a modelling study.

Autor: Puett C; Department of Family, Population & Preventive Medicine, Program in Public Health, Health Sciences Center, Stony Brook University, Stony Brook, NY, USA. Electronic address: chloe.puett@stonybrook.edu., Anderson JD 4th; Bagamian Scientific Consulting, Gainesville, FL, USA., Bagamian KH; Bagamian Scientific Consulting, Gainesville, FL, USA; Department of Environmental and Global Health, University of Florida, Gainesville, FL, USA., Muhib F; PATH, Washington, DC, USA., Scheele S; PATH, Washington, DC, USA., Hausdorff WP; PATH, Washington, DC, USA; Faculty of Medicine, Université Libre de Bruxelles, Brussels, Belgium., Pecenka C; PATH, Seattle, WA, USA.

Publikováno v: The Lancet. Global health [Lancet Glob Health] 2023 Jun; Vol. 11 (6), pp. e892-e902.

Could a Shigella vaccine impact long-term health outcomes?: Summary report of an expert meeting to inform a Shigella vaccine public health value proposition, March 24 and 29, 2021.

Autor: Bagamian KH; Bagamian Scientific Consulting, LLC, Gainesville, FL 32601, USA.; Department of Environmental and Global Health, University of Florida, Gainesville, FL 32603, USA., Puett C; Stony Brook University, Department of Family, Population & Preventative Medicine, Program in Public Health, Stony Brook, NY 11794, USA., Anderson JD 4th; Bagamian Scientific Consulting, LLC, Gainesville, FL 32601, USA., Muhib F; Center for Vaccine Innovation and Access, PATH, 455 Massachusetts Ave NW, Washington, DC 20001, USA., Pecenka C; Center for Vaccine Innovation and Access, PATH, Seattle, WA 98121, USA., Behrman J; Department of Economics and Sociology, University of Pennsylvania, Philadelphia, PA 19104, USA., Breiman RF; Hubert Department of Global Health, Rollins School of Public Health, Emory University, Atlanta, GA 30322, USA., Edoka I; Health Economics and Epidemiology Research Office, Department of Internal Medicine, School of Clinical Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.; School of Public Health, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa., Horton S; School of Public Health Sciences, University of Waterloo, Waterloo, ON N2L 3G1, Canada., Kang G; Division of Gastrointestinal Sciences, Christian Medical College, Vellore 632004, India., Kotloff KL; Department of Pediatrics, Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, MD, USA., Lanata CF; Instituto de Investigacion Nutricional, Lima, Peru., Platts-Mills JA; Division of Infectious Diseases & International Health, University of Virginia, Charlottesville, VA 22903, USA., Qadri F; International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b), Dhaka, Bangladesh., Rogawski McQuade ET; Department of Epidemiology, Emory University, Atlanta, GA 30322, USA., Sudfeld C; Department of Global Health and Population, Harvard T.H. Chan School of Public Health, Boston, MA 02115, USA., Vonaesch P; Department of Fundamental Microbiology, University of Lausanne, Switzerland., Wierzba TF; Department of Internal Medicine, Section on Infectious Diseases, Winston-Salem, NC 27157, USA., Scheele S; Center for Vaccine Innovation and Access, PATH, 455 Massachusetts Ave NW, Washington, DC 20001, USA.

Publikováno v: Vaccine: X [Vaccine X] 2022 Sep 21; Vol. 12, pp. 100218. Date of Electronic Publication: 2022 Sep 21 (Print Publication: 2022).

Heterogeneity in enterotoxigenic Escherichia coli and shigella infections in children under 5 years of age from 11 African countries: a subnational approach quantifying risk, mortality, morbidity, and stunting.

Autor: Bagamian KH; Department of Environmental & Global Health, University of Florida, FL, USA; Bagamian Scientific Consulting, Gainesville, FL, USA. Electronic address: karoun@bagamiansci.com., Anderson JD 4th; Department of Environmental & Global Health, University of Florida, FL, USA; Goodnight Family Department of Sustainable Development, Appalachian State University, Boone, NC, USA., Muhib F; PATH, Washington, DC, USA., Cumming O; Department of Disease Control, London School of Hygiene & Tropical Medicine, London, UK., Laytner LA; Department of Environmental & Global Health, University of Florida, FL, USA., Wierzba TF; PATH, Washington, DC, USA; Department of Internal Medicine, Section on Infectious Diseases, Wake Forest School of Medicine, Winston Salem, NC, USA., Rheingans R; Goodnight Family Department of Sustainable Development, Appalachian State University, Boone, NC, USA.

Publikováno v: The Lancet. Global health [Lancet Glob Health] 2020 Jan; Vol. 8 (1), pp. e101-e112. Date of Electronic Publication: 2019 Nov 14.

Potential impact and cost-effectiveness of future ETEC and Shigella vaccines in 79 low- and lower middle-income countries.

Autor: Anderson JD 4th; Goodnight Family Department of Sustainable Development, Appalachian State University, 222 Living Learning Center, 305 Bodenheimer Drive, Boone, NC 28608, USA.; Emerging Pathogens Institute, P.O. Box 100009, 2055 Mowry Road, Gainesville, FL 32610, USA., Bagamian KH; Department of Environmental and Global Health, University of Florida, Gainesville, FL 32603, USA.; Bagamian Scientific Consulting, 978 SW 2Ave., Gainesville, FL 32601, USA., Muhib F; PATH, 455 Massachusetts Ave. NW, Suite 1000, Washington, DC 20001, USA., Baral R; PATH, 201 Westlake Avenue, Suite 200, Seattle, WA 98121, USA., Laytner LA; Emerging Pathogens Institute, P.O. Box 100009, 2055 Mowry Road, Gainesville, FL 32610, USA.; Department of Environmental and Global Health, University of Florida, Gainesville, FL 32603, USA., Amaya M; Emerging Pathogens Institute, P.O. Box 100009, 2055 Mowry Road, Gainesville, FL 32610, USA.; Department of Environmental and Global Health, University of Florida, Gainesville, FL 32603, USA., Wierzba T; PATH, 455 Massachusetts Ave. NW, Suite 1000, Washington, DC 20001, USA., Rheingans R; Goodnight Family Department of Sustainable Development, Appalachian State University, 222 Living Learning Center, 305 Bodenheimer Drive, Boone, NC 28608, USA.

Publikováno v: Vaccine: X [Vaccine X] 2019 Apr 18; Vol. 2, pp. 100024. Date of Electronic Publication: 2019 Apr 18 (Print Publication: 2019).